Enb Therapeutics

Get Full Access

Description

  • ENB Therapeutics is developing therapies to break drug resistance that occurs in over 50% of cancer patients. Our lead product, ENB-001, is a first-in-class, selective small molecule endothelin B receptor (ETBR) inhibitor shown in multiple preclinical studies to significantly reduce tumor growth and prolong survival in cancer animal models. ENB-001 is the key to unlock the full therapeutic potential of immunotherapy by restoring the ability of T-cells to infiltrate tumors, inhibiting metastasis and prolonging patient survival. Granted Orphan Drug Designation by FDA in 2016, ENB-001 has solid market exclusivity and strong IP. A low cost, time efficient development program provides near-term POC within 18 months from financing. A companion diagnostic will detect ETBR pathway over-expressers creating additional opportunities for indication expansion into multiple tumor types and broader participation in the multi-billion-dollar immunotherapy market.
  • location

    Headquarters:166 Fifth Avenue , New York, New York, United States

    More
  • Enb Therapeutics phone

    Phone Number: +1 212-792-2317

  • Enb Therapeutics website

    Website: https://www.enbpharma.com

  • Enb Therapeutics employees

    Employees:8

  • Enb Therapeutics revenue

    Revenue:$1 - 10M

  • Enb Therapeutics legal name

    Legal Name:Enb Therapeutics

  • Enb Therapeutics's Social Media

    Enb Therapeutics linkedin
  • done Is this data correct?
  • |  NAICS Code: 238990  |

    Show More
Person level website identification

Chief Operating Officer for Enb Therapeutics

Sandy Harm

Chief Operating Officer

Person level website visitor identification

Sell more in less time!

Buyer intent data, anonymous visitor identification, first party data integration backed by a massive contact database that will supercharge your sales team. Schedule a demo to learn more!

View Employees

Sandy Harm

Chief Operating Officer

Sumayah Jamal

President, Co-Founder, Chief Scientific Officer

Frequently Asked Questions regarding Enb Therapeutics

  • Where are Enb Therapeutics's Headquarters?

    Enb Therapeutics's Headquarters are in 166 Fifth Avenue ,New York,New York,United States

  • What is Enb Therapeutics's phone number?

    Enb Therapeutics's phone number is +1 212-792-2317

  • What is Enb Therapeutics's official website?

    Enb Therapeutics's official website is https://www.enbpharma.com

  • What is Enb Therapeutics's Revenue?

    Enb Therapeutics's revenue is $1 - 10M

  • What is Enb Therapeutics's NAICS code?

    Enb Therapeutics's NAICS code is 238990

  • How many employees are working in Enb Therapeutics

    Enb Therapeutics has 8 employees

  • What is Enb Therapeutics's Industry?

    Enb Therapeutics is in the industry of Pharmaceuticals

  • Who is Enb Therapeutics's Chief Operating Officer?

    Enb Therapeutics's Chief Operating Officer is Sandy Harm

Company Directory